AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 InogenAvanos MedicalEstablishment LabsWound Management TechnologiesInvacare
SymbolNASDAQ:INGNNYSE:AVNSNASDAQ:ESTAOTCMKTS:WNDMNYSE:IVC
Price Information
Current Price$38.11$33.15$20.64N/A$7.86
52 Week RangeHoldHoldBuyN/ABuy
Beat the Market™ Rank
Overall Score1.32.22.10.71.7
Analysis Score3.13.13.40.03.5
Community Score3.02.12.52.62.3
Dividend Score0.00.00.00.01.7
Ownership Score0.04.04.01.00.0
Earnings & Valuation Score0.61.90.60.01.3
Analyst Ratings
Consensus RecommendationHoldHoldBuyN/ABuy
Consensus Price Target$60.80$36.00$26.75N/A$14.00
% Upside from Price Target59.54% upside8.60% upside29.60% upsideN/A78.12% upside
Trade Information
Market Cap$872.85 million$1.45 billion$484.31 million$2.40 billion$236.16 million
Beta0.741.181.471.91.17
Average Volume417,979410,297129,23284,782453,350
Sales & Book Value
Annual Revenue$361.94 million$697.60 million$89.57 million$5.84 million$927.96 million
Price / Sales2.322.275.380.000.29
Cashflow$1.70 per share$2.11 per shareN/AN/A$0.11 per share
Price / Cash22.4115.73N/AN/A68.76
Book Value$15.67 per share$26.40 per share$1.92 per shareN/A$8.20 per share
Price / Book2.431.2610.75NaN0.96
Profitability
Net Income$20.95 million$-45,900,000.00$-38,150,000.00$-600,000.00$-53,330,000.00
EPS$1.07$1.07($1.86)N/A($1.06)
Trailing P/E Ratio60.49N/AN/A0.00N/A
Forward P/E Ratio65.7129.08N/AN/AN/A
P/E GrowthN/A$3.70N/AN/AN/A
Net Margins3.90%-3.07%-48.39%-10.28%-4.19%
Return on Equity (ROE)4.93%4.09%-75.95%-39.28%-10.17%
Return on Assets (ROA)3.84%2.90%-34.02%-21.49%-3.73%
Dividend
Annual PayoutN/AN/AN/AN/A$0.05
Dividend YieldN/AN/AN/AN/A0.64%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%0.24%0.54%1.35%0.66%
Current Ratio5.43%2.77%6.58%2.42%1.27%
Quick Ratio4.75%1.96%5.45%2.42%0.87%
Ownership Information
Institutional Ownership PercentageN/A94.15%53.33%N/AN/A
Insider Ownership Percentage4.83%1.51%2.64%75.40%3.20%
Miscellaneous
Employees1,0204,700505133,900
Shares Outstanding22.05 million47.76 million23.33 million236.64 million34.43 million
Next Earnings Date8/5/2020 (Estimated)8/4/2020 (Estimated)8/11/2020 (Estimated)N/A8/3/2020 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.